Cashu
Shkreli Advocates for Q/C Technologies' Leadership in the Future of Photonic Computing
26 days ago
Stocks
Health Care
qcls
Q/C Technologies
NASDAQ: QCLS
+0.06 (+1.76%)
3.46
USD
At close at Apr 03, 20:38 UTC
Overview
Loading chart...
Key Stats
Market Cap
6.11M
Dividend Yield
0.00%
P/E Ratio
-0.53
EPS
-1141.62
Revenue
-
Avg. Volume
312.95K
About
What does QCLS do?
MyMD Pharmaceuticals, based in Baltimore, develops drug products for aging, autoimmune diseases, and chronic pain, focusing on two platforms: MYMD-1 for inflammation and Supera-CBD for pain and addiction. The company went public in 2008 and employs nine people.
Sector
💻 Health Care
IPO
CEO
Employees
2
Headquarters
New York, USA
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.